Please use this identifier to cite or link to this item: https://doi.org/10.2174/187152210791171296
DC FieldValue
dc.titleAntiviral immunotherapy for mosquito-borne flaviviruses: A review of current status
dc.contributor.authorChen, JC
dc.contributor.authorChia, PY
dc.contributor.authorNg, MML
dc.contributor.authorChu, JJH
dc.date.accessioned2020-06-25T14:41:42Z
dc.date.available2020-06-25T14:41:42Z
dc.date.issued2010-01-01
dc.identifier.citationChen, JC, Chia, PY, Ng, MML, Chu, JJH (2010-01-01). Antiviral immunotherapy for mosquito-borne flaviviruses: A review of current status. Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry 10 (1) : 31-42. ScholarBank@NUS Repository. https://doi.org/10.2174/187152210791171296
dc.identifier.issn18715222
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/170742
dc.description.abstractMosquito-borne flaviviruses are a group of viruses belonging to the genus flavivirus and the family flaviviridae. Dengue Virus, Yellow Fever Virus, Japanese Encephalitis Virus and West Nile Virus are some examples of the medically important flaviviruses. The disease manifestations of these flaviviruses range from the mild febrile fever to the life-threatening encephalitis and hemorrhagic manifestation. Mosquito-borne flaviviruses are human pathogens of increasing global importance as they become more prevalent due to changes in the world climate and globalization. Extensive research has been carried out to understand these viruses and to devise ways to effectively treat the diseases caused by these mosquito-borne flaviviruses. However, no effective anti-viral treatment for these flaviviruses is currently available. Many novel anti-viral immunotherapy approaches are now being undertaken to find ways to effectively counter these viruses. This review will outline the potential anti-viral immunotherapies that can be used to treat these mosquito-borne flavivirus infections. Various strategies used for the discovery of potentially therapeutic antibody against these flaviviruses will also be discussed. © 2010 Bentham Science Publishers Ltd.
dc.publisherBentham Science Publishers Ltd.
dc.sourceElements
dc.subjectAntibody
dc.subjectAntiviral
dc.subjectCorticosteroid
dc.subjectFlavivirus
dc.subjectImmunoglobulin
dc.subjectImmunotherapy
dc.subjectInterferon
dc.subjectIntravenous
dc.typeArticle
dc.date.updated2020-06-23T09:52:23Z
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.description.doi10.2174/187152210791171296
dc.description.sourcetitleImmunology, Endocrine and Metabolic Agents in Medicinal Chemistry
dc.description.volume10
dc.description.issue1
dc.description.page31-42
dc.identifier.isiutNOT_IN_WOS
dc.description.placeNETHERLANDS
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
0004P.pdfPublished version233.12 kBAdobe PDF

OPEN

Post-printView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.